SUPPORTED BY RELMADA THERAPEUTICS, INC
In this custom video series, experts in sleep and neuroscience discuss the role of neurologists, psychiatrists, and sleep specialists in the treatment of narcolepsy and comorbid conditions.
Here’s why we should be paying special attention to women's depression treatment.
In a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
Treating patients who may be perceived as “unlikeable” can be difficult.
The pandemic's effect on the mental health and addiction communities has been severe. Luckily, there's a temporary solution: telemedicine.
Stigma poses a serious risk to quality of care and accessibility.
These 2 medical students want to share their helpful handouts with you and your patients. Watch the video to learn more.
For students with mental health diagnoses, this program can help with enrolling or re-enrolling in college.
Considering challenges and opportunities in digital health solutions for mental health care.
Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% go on to develop a chronic and unremitting course of AN. How can we improve these outcomes?
What are some practical ideas for helping families who may be dealing with a COVID-19 death?
How can you better provide care for American Indians and Alaska Natives?
Fatigue is a very common physical complaint. What therapeutic options are available?
This form of nonsuicidal self-injury occurs within a spectrum of severity, and it is very likely that cases are both underreported and unpublished.
What is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?
In this CME article, learn how to apply novel treatment approaches for patients with bipolar depression.
"The psychiatrist may be obligated to protect the fetus or warn authorities of the patient’s intent."
More than half of physicians believe that seeking psychiatric care would jeopardize their employment. What can be done?
New data out of Maryland includes some surprising numbers.
Although botulinum toxin does not have regulatory approval for the treatment of depression in the United States, some reports indicate neurotoxin treatment may mitigate symptoms.
The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.
Experts preview their upcoming presentation on women in psychiatry at the 2023 APA Annual Meeting.
With so much media surrounding mass violence in the US, we need to sort out fact from fiction.
Presenting the second-prize winner of the 2022 Gerald F. Berlin Creative Writing Award.
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
How can we address—and solve—2 of the biggest hurdles for patients in receiving mental health care?
Psychiatric Times’ Substance Use Section Editor weighs in on the FDA approval of the first naloxone product for nonprescription use.
How can you be better prepared to interview and care for peripartum patients? This CME shows you how.